Osteonic Co. Ltd (226400) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Osteonic Co. Ltd (226400) has a cash flow conversion efficiency ratio of 0.017x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.09 Billion ≈ $738.58K USD) by net assets (₩63.89 Billion ≈ $43.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Osteonic Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Osteonic Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Osteonic Co. Ltd (226400) total liabilities for a breakdown of total debt and financial obligations.
Osteonic Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Osteonic Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nan Liu Enterprise Co Ltd
TW:6504
|
-0.010x |
|
Resource Alam Indonesia Tbk
JK:KKGI
|
-0.087x |
|
DHI Group Inc
NYSE:DHX
|
0.049x |
|
Barington/Hilco Acquisition
NASDAQ:BHAC
|
-0.004x |
|
US Masters Residential Property Fund
AU:URF
|
-0.013x |
|
Berjaya Food Bhd
KLSE:5196
|
-0.045x |
|
The Sandesh Limited
NSE:SANDESH
|
0.018x |
|
CeoTronics AG
F:CEK
|
0.061x |
Annual Cash Flow Conversion Efficiency for Osteonic Co. Ltd (2015–2024)
The table below shows the annual cash flow conversion efficiency of Osteonic Co. Ltd from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see Osteonic Co. Ltd market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩59.32 Billion ≈ $40.20 Million |
₩4.72 Billion ≈ $3.20 Million |
0.080x | -0.34% |
| 2023-12-31 | ₩51.88 Billion ≈ $35.16 Million |
₩4.14 Billion ≈ $2.81 Million |
0.080x | -26.91% |
| 2022-12-31 | ₩36.50 Billion ≈ $24.74 Million |
₩3.99 Billion ≈ $2.70 Million |
0.109x | +31.70% |
| 2021-12-31 | ₩35.53 Billion ≈ $24.08 Million |
₩2.95 Billion ≈ $2.00 Million |
0.083x | -26.84% |
| 2020-12-31 | ₩24.28 Billion ≈ $16.46 Million |
₩2.75 Billion ≈ $1.86 Million |
0.113x | +233.50% |
| 2019-12-31 | ₩28.96 Billion ≈ $19.62 Million |
₩-2.46 Billion ≈ $-1.67 Million |
-0.085x | -861.84% |
| 2018-12-31 | ₩28.50 Billion ≈ $19.31 Million |
₩317.53 Million ≈ $215.19K |
0.011x | +110.40% |
| 2017-12-31 | ₩7.43 Billion ≈ $5.03 Million |
₩-795.80 Million ≈ $-539.30K |
-0.107x | +27.68% |
| 2016-12-31 | ₩11.68 Billion ≈ $7.91 Million |
₩-1.73 Billion ≈ $-1.17 Million |
-0.148x | +26.46% |
| 2015-12-31 | ₩6.35 Billion ≈ $4.30 Million |
₩-1.28 Billion ≈ $-866.78K |
-0.201x | -- |
About Osteonic Co. Ltd
Osteonic Co., Ltd. develops, manufactures, and sells bone fixation systems. It offers CMF systems, including neuro plating systems, maxillofacial plating systems, mandible plating systems, IMF screws, power screw drivers, 90 angled screw driver, customized neuro 3D mesh, and mandible reconstruction plates under the OPTIMUS and Real FIT brand names; and biodegradable CMF plating systems under the … Read more